| In millions, except per share items | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K |
| Cash Flows From Operating Activities: | | |
| Net loss | -7.9 | -4.1 |
| Adjustments to reconcile net loss to net cash used in operating activities: | | |
| Bad debt expense | 0.0 | 0.0 |
| Depreciation and amortization | 0.3 | 0.0 |
| Common stock | 0.5 | 0.0 |
| Changes in operating assets and liabilities: | | |
| Accounts receivable | -1.3 | 0.3 |
| Other receivable | -1.3 | 0.3 |
| Prepaid expenses and other current assets | -0.1 | 0.0 |
| Accounts payable - suppliers | -0.2 | -0.2 |
| Accounts payable - trade | 0.2 | 0.6 |
| Accrued expenses and other current liabilities | 0.2 | 0.0 |
| Accrued interest | 0.2 | |
| Net Cash Used In Operating Activities | -4.8 | -2.7 |
| |
| Cash Flows From Investing Activities: | | |
| Purchase of property and equipment | 0.0 | 0.0 |
| Net Cash Used In Investing Activities | -1.3 | -0.1 |
| |
| Cash Flows From Financing Activities: | | |
| Proceeds from exercise of warrants | 0.0 | |
| Payment of deferred offering costs | | -0.1 |
| Net Cash (Used In) Provided By Financing Activities | 30.9 | 2.8 |
| |
| Supplemental Disclosures of Cash Flow Information: | | |
| Cash paid during the period for: | | |
| Interest | 0.0 | 0.0 |
| Non-cash investing and financing activities: | | |